Skip to main content

Author: Leigh MacMillan

Bioethics expert Kahn to deliver next Discovery Lecture

Sep. 20, 2018—Noted bioethicist Jeffrey Kahn, PhD, MPH, will deliver the next Flexner Discovery Lecture on Thursday, Sept. 27.

Read more


Healthy antibodies reverse diabetes

Sep. 13, 2018—Vanderbilt researchers have discovered that IgM-type antibodies appear to play a protective role to prevent the development of type 1 diabetes — and that purified IgM antibodies can reverse the disease.

Read more


Link between immune system, disease explored

Sep. 6, 2018—The first Flexner Discovery Lecture of the academic year featured presentations by two Vanderbilt faculty members.

Read more


Unleashing TIGER on small RNAs

Sep. 5, 2018—Vanderbilt investigators have developed a new analytical tool to identify, quantify and analyze small RNAs.

Read more


Using light to fight GVHD

Aug. 30, 2018—Extracorporeal photopheresis treatment for stem cell transplant-related complications produces a response in up to 60 percent of patients.

Read more


Investigators find that bile acids reduce cocaine reward

Aug. 30, 2018—Bile acids — gut compounds that aid in the digestion of dietary fats — reduce the desire for cocaine, according to a new study by researchers at Vanderbilt and the University of Alabama at Birmingham.

Read more


Carrasco to lead Molecular Physiology and Biophysics at VU

Aug. 23, 2018—Nancy Carrasco, MD, a leading figure in the study of iodide transport and its critical role in the thyroid and mammary glands, has been named chair of Vanderbilt University’s Department of Molecular Physiology and Biophysics.

Read more


Madhur, Smith set to deliver fall season’s first Discovery Lecture

Aug. 23, 2018—The Flexner Discovery Lecture series kicks off the academic year next week with presentations by two Vanderbilt faculty members. The Cutting-Edge Discovery Lectures by Meena Madhur, MD, PhD, and Scott Smith, MD, PhD, begin at 4 p.m. on Thursday, Aug. 30 in 208 Light Hall.

Read more


Risk factors for faulty rhythms

Aug. 16, 2018—Risk factors for arrhythmias after heart surgery in infants include medications, infant age and higher surgical complexity, but not two genetic variants examined by Vanderbilt researchers.

Read more


A new target for lung cancer

Aug. 16, 2018—Vanderbilt researchers have identified a new vulnerability in lung cancer — the transporter protein xCT — that may a therapeutic target for the disease.

Read more


Genetic balancing act

Aug. 2, 2018—New findings about proteins involved in DNA repair are important for understanding why some cancers are more or less resistant to certain therapies.

Read more


Connecting an asthma gene to leukemia

Aug. 2, 2018—A receptor previously implicated in asthma may also play roles in other allergic diseases and in leukemia, Vanderbilt researchers have discovered.

Read more


Page 1 of 4312345678...Last »

Recent Stories from VUMC News and Communications Publications

Brighter days ahead

Vanderbilt Medicine

Brighter days ahead

Community care

Vanderbilt Nurse

Community care

Survive and thrive

Hope

Survive and thrive

Combating cancer disparities is an out-of-office assignment

Momentum

Combating cancer disparities is an out-of-office assignment

more